Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01721200 · ClinicalTrials.gov registry record · NA

"Learning About Biologics"-Rheumatoid Arthritis

A NA study of Rheumatoid Arthritis, sponsored by Geisinger Clinic.

Completed
Registry status
NA
Development phase
125
Enrollment target
1
Study location

NCT01721200: Completed NA study of Rheumatoid Arthritis, sponsored by Geisinger Clinic.

NCT01721200 is a NA study of Rheumatoid Arthritis that has completed, run by Geisinger Clinic. The registered enrollment target is 125 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01721200, a NA study of Rheumatoid Arthritis, has completed, sponsored by Geisinger Clinic.

COMPLETED
Registry status
NA
Development phase
125 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized controlled trial designed to examine the efficacy of an educational decision support tool for patients with rheumatoid arthritis who continue to have active disease despite use of traditional disease modifying drugs. The study will take place at Geisinger Medical Center in Danville, PA. Eligible subjects will be identified by the treating physician and those providing consent will be randomized to usual care versus use of the decision support tool.

Primary Outcome

We classified subjects as having made an informed choice to escalate care if they answered at least 75% of the knowledge questions correctly and had low decisional conflict as defined by a score of 25 or lower on the combined subjective knowledge and values clarity subscales.

Conditions Studied

Interventions

  • OTHER Usual Care
  • OTHER Decision Support Tool

Study Locations (1)

Pennsylvania

  • Geisinger Medical Center - Danville

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2012-11
Est. Completion 2015-02
Phase NA
Geisinger Clinic

107 total trials

What the finished NCT01721200 record still lists

NCT01721200 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT01721200 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01721200 about?

NCT01721200 is a clinical study titled ""Learning About Biologics"-Rheumatoid Arthritis". This study is a randomized controlled trial designed to examine the efficacy of an educational decision support tool for patients with rheumatoid arthritis who continue to have active disease despite use of traditional disease modifying drugs. The study will take place at Geisinger Medical Center in...

What is the current status of trial NCT01721200?

This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2012-11. Estimated completion is 2015-02.

What conditions does trial NCT01721200 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

What interventions are being tested in trial NCT01721200?

The interventions under investigation include: Usual Care (OTHER), Decision Support Tool (OTHER).

Who is sponsoring clinical trial NCT01721200?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01721200 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01721200's enrollment target sits among peer trials

125 107th of 197 higher than 91 of 197 other Rheumatoid Arthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02717039 · 125 participants

    Pharmacogenomics of Heparin-Induced Thrombocytopenia

  • NCT02763033 · 125 participants · Phase 2

    Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

  • NCT02793999 · 125 participants

    Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia

  • NCT03003299 · 125 participants · NA

    PARTNER 3 Trial - Aortic Valve-in-Valve

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01721200, the US trial registry maintained by the National Library of Medicine. NCT01721200 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.